TrialBreast cancer research and treatment2023

Investigating potential immune mechanisms of trilaciclib administered prior to chemotherapy in patients with metastatic triple-negative breast cancer.

Antoinette R Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.